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its potential toxic effects. Mercury is a naturally occurring metallic element, which can be found as Hg or
inorganic and organic salts. In this article we will review the risks of exposure and toxicity of each of the
forms of mercury, including some of the current guidance concerning the risks of mercury toxicity from
eating fish, dental amalgam and vaccinations containing mercury (thiomersal) preservatives.
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ABSTRACT Recently there has been a lot of interest in the medical and lay press
concerning exposure to mercury and its potential toxic effects. Mercury is a
naturally occurring metallic element, which can be found as Hg or inorganic and
organic salts. In this article we will review the risks of exposure and toxicity of
each of the forms of mercury, including some of the current guidance concerning
the risks of mercury toxicity from eating fish, dental amalgam and vaccinations
containing mercury (thiomersal) preservatives.
KEYWORDS Dental amalgam, ethylmercury, methylmercury, mercury, thiomersal
LIST OF ABBREVIATIONS central nervous system (CNS), elemental mercury (Hg),
European Medicines Evaluation Agency (EMEA), Food and Drug Administration
(FDA), Health Protection Agency (HPA),World Health Organisation (WHO)

Published online January 2006
Correspondence to D Wood, Guy's
and St Thomas' Poisons Unit,
Medical Toxicology Unit, Avonley
Road, London, SE14 5ER
tel. +44 (0)20 7771 5315
fax. +44 (0)20 7771 5306
e-mail David.Wood@gstt.nhs.uk

DECLARATION OF INTERESTS No conflict of interests declared.

ELEMENTAL MERCURY
Elemental mercury (Hg) is a metallic liquid under normal
conditions, and has been used in thermometers and
sphygmomanometers. Ingestion of liquid elemental
mercury is of low toxicity, since it is very poorly absorbed
from the gastrointestinal tract. Therefore broken oral or
rectal thermometers are usually of little toxicological
significance, unless the patient has significantly reduced
gastrointestinal transit time, or has ingested very large
amounts of elemental mercury. However, if the contents
are spilled onto a surface such as a carpet and the vapour
is then inhaled over a period of time, systemic absorption
and toxicity can occur. It is important that a vacuum
cleaner is not used to clean up spilt elemental mercury,
due to volatilisation of the mercury and inhalation of the
vapour. Spilt elemental mercury can be cleaned up using
specialised kits available from most chemists and these
include instructions on its safe disposal. It is poorly
absorbed following dermal contact.

urinary mercury concentrations should be obtained and
chelation therapy may be required, following discussion
with a clinical toxicologist. Patients who develop severe
respiratory symptoms and survive, may develop late
sequelae, including interstitial fibrosis and residual
restrictive pulmonary disease
Chronic exposure to elemental mercury can lead to nonspecific symptoms, which include gastrointestinal
disturbances, headache and neurological features including
depression, irritability, insomnia, confusion, forgetfulness
and intellectual deterioration. Chronic exposure can
occur following repeated oral ingestion of low
concentrations of mercury or by wrongly using a vacuum
cleaner to clean up elemental mercury spillages, where
the mercury continues to be vaporised each time it is
used. Blood and urine mercury concentrations should be
measured following discussion with a clinical toxicologist;
chelation therapy may be required.

ORGANIC MERCURY SALTS
Toxicity from elemental mercury occurs from
volatilisation of significant quantities since it is freely
absorbed through the respiratory tract epithelium. Initial
symptoms include nausea, vomiting, acute breathlessness,
pyrexia, headache and visual disturbances. Patients may
also complain of a metallic taste and associated
hypersalivation. Respiratory symptoms can progress to
pulmonary oedema and respiratory failure. Patients will
require good supportive care, with ventilatory support if
significant respiratory symptoms occur. Blood and

120

Organic mercury salts have previously been used as
fungicides, but significant exposure to organic mercury
salts in humans usually occurs due to ingestion of
methylmercury in fish and ethylmercury when thiomersal
is used as a preservative in vaccinations. Organic mercury
salts are readily absorbed from the gastrointestinal tract,
with up to 90% absorption. Since the risk of exposure
and therefore toxicity differs between the two organic
mercury salts, each will be discussed separately.

Methylmercury

Ethylmercury

Bacteria metabolising inorganic mercury salts produce
methylmercury. Accumulation can occur in fish and
shellfish, with higher concentrations in fish higher in
the food chain, where there is contamination of water
with industrial effluent containing inorganic mercury
salts. Methylmercury, when ingested in contaminated
fish, has a longer half-life of approximately 50 days, so
that accumulation can occur in people who ingest
large amounts of fish. Specific amino acid transporters
can transport methylmercury across the blood-brain
barrier, leading to CNS accumulation.
Focal
neurological toxicity can occur, and the visual cortex
and cerebellum are particularly at risk. The evidence
for neurological toxicity in adults from fish is
inconclusive. In a Faeroese population, who ingest
large amounts of whale meat, exposure to higher
concentrations of methylmercury was reported to be
associated with deficits in attention, language and
memory. However, in this study, ingestion of higher
concentrations of polychlorinated biphenyls in whale
meat was a confounding factor. Recent cardiological
studies have shown that fish containing high quantities
of omega-3 fish oils, is associated with a reduction in
cardiovascular risk and patients are recommended to
eat up to four portions of oily fish per week. This will
increase the risk of methylmercury exposure, and this
cardiovascular benefit of omega-3 fish oils outweighs
the risk of methylmercury toxicity. Some fish, such as
salmon, have been shown to have lower
concentrations of methylmercury than tuna or
swordfish and over the counter preparations
containing fish oils have been shown not to contain
significant concentrations of methylmercury.

Thiomersal has previously been used as a preservative in
vaccinations, and is metabolised to form ethylmercury.
The amount of thiomersal previously used in vaccines was
12·5 to 25 μg per 0·5 ml vaccine, and studies have shown
an increase in ethylmercury concentrations of up to 50fold, with the risk increasing with multiple vaccinations.
The risks associated with elevated ethylmercury
concentrations
following
vaccinations
remains
controversial. Ethylmercury has less neurotoxicity than
methylmercury, since there is no specific uptake
mechanism across the blood-brain barrier, and it has a
shorter half-life. Previous studies have suggested a risk of
neuro-developmental delays following vaccination with
vaccines containing thiomersal, although the data is not
robust and is inconclusive. Additionally, following the
removal of thiomersal from vaccines, there have been
population studies to support a causative role of
ethylmercury in developmental delay. Despite the lack of
evidence for a direct causative neurological toxic effect of
thiomersal, and therefore ethylmercury, the EMEA and
HPA have issued guidance in 2004, which acknowledges
the lack of evidence of a neurological toxicity from
thiomersal but recommends that alternative preservatives
are used in future vaccine production.

The amino acid transporters are also present in the
placenta, and thus maternal–foetal transfer of
methylmercury can occur, leading to foetal accumulation.
Previous studies have shown that foetal brain
accumulation is more diffuse and may lead to subsequent
cerebral palsy, deafness, blindness and neurological
developmental delay. Due to this risk of foetal
neurological toxicity of methylmercury, the WHO in 2003
issued advice that the recommended weekly intake of
methylmercury in pregnant women should be reduced
from 3·3 to 1·6 μg/kg body weight. Further guidance from
the US FDA has recommended that pregnant women
limit their intake to one portion of fish per week.
However given the long half-life of methylmercury, this
advice will mean that women who have eaten large
amounts of fish prior to pregnancy will still be placing the
foetus at risk of methylmercury toxicity. There is
currently no guidance on the amount of fish or
methylmercury ingestion that women should follow
before becoming pregnant, although it is logical that the
advice for pregnant women should be followed with a six
month lower fish consumption period.
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INORGANIC MERCURY SALTS
Inorganic mercury salts, such as mercuric chloride (HgCl2)
and mercuric sulphate (HgSO4) have been used in topical
medical preparations as anti-microbial agents and for skin
whitening. Topical application of inorganic mercuric salts
can lead to skin irritation, vesication and corrosive burns.
The risk of localised toxicity is dependent on the
solubility of the mercury salt, and is greater for mercuric
chloride. Following dermal exposure to inorganic
mercury salts, the area should be thoroughly irrigated
with water and any resultant corrosive burns should be
treated conventionally.
Oral ingestion of inorganic mercury salts causes direct
corrosive effects on gastrointestinal tract, leading to
haemorrhage, massive fluid loss and shock. Approximately
10% of inorganic mercury is absorbed from the
gastrointestinal tract following oral ingestion, and the
kidney is particularly at risk of toxicity, and acute renal
failure can result. This is due in part to hypovolaemia
secondary to the gastrointestinal effects and also a direct
toxic effect of mercury on the renal tubules. In patients
who present early following ingestion, where there are
gastrointestinal corrosive features, gut decontamination
with gastric lavage and/or whole bowel irrigation should be
considered. Meticulous supportive care is required with
adequate fluid resuscitation, upper gastrointestinal
endoscopy and renal replacement if appropriate. Blood and
urine mercury concentrations should be measured, and the
need for chelation discussed with a clinical toxicologist.
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DENTAL AMALGAM
The majority of dental fillings undertaken in the United
Kingdom still use amalgam for the filling. The mercury
contained in the dental amalgam is a mixture of elemental
mercury (60–70%) and inorganic mercuric salts.
Concerns have been raised as to whether patients with
numerous fillings should have them removed, and
replaced with non-amalgam fillings. The main risk with
dental amalgam is to dental practitioners and their staff,
since the mercury has to be heated to liquidise it prior to
the procedure. Therefore dental practitioners are at risk
of inhaling significant quantities of elemental mercury
vapour if safe working practices are not in place. From a
patient’s perspective, there have been previous studies
that have concluded that there is no correlation between
the number of dental fillings and blood and urinary
mercury concentrations. Additionally there is no risk
during the insertion of dental fillings. However, removal of
dental amalgam could potentially put patients at risk of
mercury toxicity. During the removal, the fillings are
drilled out which creates fine particulate matter,
containing both elemental mercury and inorganic
mercury salts. Depending on the size of the particulate
matter, this can be inhaled, oxidised and lead to mercury
toxicity. Therefore the advice is that the insertion of
amalgam in dental fillings does not pose a risk to patients
and that the removal of dental amalgam may pose a
greater risk than leaving the dental amalgam in situ.*

long-term neurological sequlae. Prevention of mercury
toxicity is better, more rational and easier than its
treatment. Removal of thiomersal in vaccinations,
replacement of mercury containing thermometers and
sphygmomanometers, and advice concerning ingestion of
fish, are reducing the risk of exposure to significant
amounts of mercury. There is no evidence for toxicity
from dental amalgam fillings and that the removal of
dental amalgam could potentially pose a greater risk to
patients than leaving the fillings in situ.
KEYPOINTS
• Elemental mercury is non-toxic when ingested, but

•

•

•
•

inhalation of elemental mercury vapour can be
associated with toxicity.
There is no conclusive evidence in adults of
neurotoxicity with repeated ingestion of
methylmercury, which is produced by bacterial
metabolism of organic mercury salts and
accumulated in fish.
Thiomersal has been removed as a vaccine
preservative since it is metabolised to ethylmercury,
but there is no conclusive evidence of associated
neurotoxicity.
Inorganic mercury salts can cause severe toxicity and
death when ingested.
Mercury containing dental amalgam does not give
rise to mercury poisoning in patients, but may be an
environmental hazard for dental staff.

Poisoning with mercury and its salts can produce both
serious acute and potentially fatal toxicity and significant
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